Acist Medical Systems Inc. announced results from the ACIST-FFR Study demonstrating the consistent and correlative performance of the Navvus MicroCatheter compared to standard pressure wire systems. ACIST-FFR (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) is the largest multi-center study to compare microcatheter FFR to pressure wire FFR, as well as the only study to include multiple pressure wire comparators. The study was presented for the first time at EuroPCR 2017, May 16-19 in Paris, France.

MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear medicine images. The vendor-neutral application offers viewing of positron emission tomography (PET)/computed tomography (CT), single photon emission computed tomography (SPECT)/CT, PET/magnetic resonance imaging (MRI) and general nuclear medicine images. Physicians and technologists can streamline the nuclear medicine workflow by viewing and processing images in tandem using this single-platform solution.

BioVentrix Inc. recently announced the first clinical use of its closed-chest Revivent TC TransCatheter Ventricular Enhancement System at the Deutsches Herzzentrum Berlin in Germany. The Less Invasive Ventricular Enhancement (LIVE) procedure was performed by interventional cardiologist Christoph Klein, M.D., and cardiothoracic surgeon Felix Hennig, M.D., with important contributions from Sebastian Kelle, M.D., chief of cardiovascular imaging.

May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare costs and healthcare resource utilization (HCRU) among novel oral anticoagulants (NOACs) were presented at the International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting in Boston. Boehringer Ingelheim Pharmaceuticals issued a press release regarding the study results.

A Canadian cardiologist has published a report in the journal Eurointervention describing how he used a Canadian-invented device for the first time in the world to successfully insert a MitraClip through a patient's jugular vein rather than the femoral vein.

The U.S. Food and Drug Administration (FDA) announced that it has granted market clearance to Ra Medical Systems for the company’s DABRA (Destruction of Ateriosclerotic Blockages by laser Radiation Ablation) System.

Early results from the independent, physician-sponsored FFR-Search Registry revealed an association between post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) measurements with the Acist Navvus Rapid Exchange FFR MicroCatheter and clinical outcomes. The results reveal a potential new role for FFR in cath labs.

May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a late-breaking clinical trial session at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now